| Bioactivity | BET-IN-16 (Comp I) is a BET inhibitor. BET-IN-16 shows anticancer activity. BET-IN-16 inhibits prostate cancer cell growth, with IC50 values of 0.043 and 0.034 μM against LNCaP and 22Rv1 cells, respectively[1]. |
| Name | BET-IN-16 |
| CAS | 2089390-09-8 |
| Formula | C31H25N5O3 |
| Molar Mass | 515.56 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ben Powell, et al. Combinational drug anticancer therapies. Patent, WO2022040512A1. |
BET-IN-16
CAS: 2089390-09-8 F: C31H25N5O3 W: 515.56
BET-IN-16 (Comp I) is a BET inhibitor. BET-IN-16 shows anticancer activity. BET-IN-16 inhibits prostate cancer cell grow
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.